Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TKTX-Cream
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
TKTX-Cream is a topical anesthetic formulation containing combinations of lidocaine, prilocaine, and epinephrine (adrenaline). It is primarily used for pain relief during procedures such as tattooing, permanent makeup, microneedling, laser treatments, and venipuncture. The product comes in different color variants (yellow, gold, black, red, white, blue) with varying absorption characteristics.
- Brand names
- TKTX NumbTKTX Numbing CreamTKTX-Cream
- Other names
- Tattoo cream
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on TKTX-Cream.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TKTX-Cream.